NYSE · CIK 0000884121
HQL abrdn Life Sciences Investors
Insider trading from SEC Form 4. Last filing Jul 20, 2026. Close $18.15 on Oct 9, 2026, +29% from the 52-week low and -18% from the high.
In brief
abrdn Life Sciences Investors (HQL) has 22 SEC Form 4 filings on file from 3 insiders, the latest filed on Jul 20, 2026. In the last 90 days insiders made 1 open-market buy worth $10k and 0 open-market sells worth $0, net +$10k.
22 open-market trades have been scored at HQL. The newest: Chris LaVictoire Mahai (director) bought $10k of stock on Jul 16, 2026, filed Jul 20, 2026, scored 23 (weak). The largest of the 22 shown: Saba Capital Management, L.P. (10% owner) sold $906k on Sep 17, 2025, scored 36 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at abrdn Life Sciences Investors, scored.
Transactions
Every row filed, 28 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Chris LaVictoire Mahai director | POpen-market purchase Common Stock | +527 | $19.92 | $10k | 527 | Jul 20, 2026 |
| Dec 16, 2025 | Christian Pittard director | POpen-market purchase Common Stock | +7,923 | $16.88 | $134k | 7,923 | Dec 18, 2025 |
| Sep 19, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -6,989 | $14.10 | $99k | 2,879,256 | Sep 23, 2025 |
| Sep 22, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -41,623 | $14.14 | $589k | 2,837,633 | Sep 23, 2025 |
| Sep 17, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -24,328 | $13.99 | $340k | 2,926,453 | Sep 19, 2025 |
| Sep 18, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -40,208 | $14.07 | $566k | 2,886,245 | Sep 19, 2025 |
| Sep 15, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -700 | $14.13 | $9,891 | 2,952,807 | Sep 17, 2025 |
| Sep 16, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -2,026 | $13.99 | $28k | 2,950,781 | Sep 17, 2025 |
| Sep 11, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -15,116 | $14.28 | $216k | 2,953,507 | Sep 15, 2025 |
| Sep 2, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -14,083 | $14.04 | $198k | 2,968,623 | Sep 4, 2025 |
| Aug 29, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -23,723 | $13.89 | $330k | 2,982,706 | Sep 2, 2025 |
| Aug 26, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -400 | $13.83 | $5,532 | 3,006,429 | Aug 27, 2025 |
| Aug 21, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -10,710 | $14.07 | $151k | 3,006,829 | Aug 25, 2025 |
| May 20, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -11,419 | $12.71 | $145k | 3,017,539 | May 22, 2025 |
| May 15, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -23,729 | $12.08 | $287k | 3,028,958 | May 19, 2025 |
| May 13, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -730 | $12.28 | $8,964 | 3,053,287 | May 15, 2025 |
| May 14, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -600 | $12.04 | $7,224 | 3,052,687 | May 15, 2025 |
| May 8, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -12,689 | $11.98 | $152k | 3,054,017 | May 12, 2025 |
| May 7, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -1,366 | $12.19 | $17k | 3,066,706 | May 8, 2025 |
| Apr 17, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -9,144 | $11.78 | $108k | 3,068,072 | Apr 21, 2025 |
| Apr 15, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -1,700 | $11.92 | $20k | 3,077,216 | Apr 17, 2025 |
| Apr 14, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -15,400 | $11.67 | $180k | 3,078,916 | Apr 15, 2025 |
| Apr 10, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -30,156 | $11.14 | $336k | 3,094,316 | Apr 14, 2025 |
| Apr 3, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -10,321 | $12.23 | $126k | 3,131,361 | Apr 7, 2025 |
| Apr 4, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -6,889 | $11.57 | $80k | 3,124,472 | Apr 7, 2025 |
| Apr 1, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -17,621 | $12.45 | $219k | 3,170,784 | Apr 3, 2025 |
| Apr 2, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -29,102 | $12.28 | $357k | 3,141,682 | Apr 3, 2025 |
| Mar 31, 2025 | Saba Capital Management, L.P. owner | SOpen-market sale Common Stockindirect: - | -48,623 | $12.58 | $612k | 3,188,405 | Apr 1, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Chris LaVictoire Mahaidirector
- Christian Pittarddirector
- Saba Capital Management, L.P.owner
Questions about HQL
Answered from the filings on this page, as of the latest one.
Are insiders buying HQL?
As of Jul 20, 2026, SEC Form 4 filings show 1 open-market buy worth $10k by 1 insider and 0 open-market sells worth $0 by 0 insiders at abrdn Life Sciences Investors in the last 90 days, net +$10k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade HQL on the open market?
Chris LaVictoire Mahai (director) bought $10k of HQL on Jul 16, 2026 and filed the Form 4 on Jul 20, 2026. InsiderTell scored 23 (weak).
How many insiders file Form 4 at abrdn Life Sciences Investors?
3 people have filed a Form 4 at abrdn Life Sciences Investors, among them Chris LaVictoire Mahai (director), Christian Pittard (director), Saba Capital Management, L.P. (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.